ArticleFrontiers in pharmacology2024

CBX2 enhances the progression and TMZ chemoresistance of glioma via EZH2-mediated epigenetic silencing of PTEN expression.

Jian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.